Harrisvaccines is an innovative animal vaccine producer based in Ames, Iowa. Because Harrisvaccines utilizes state-of-the-art RNA technology not widely recognized in the industry, they face several regulatory challenges and have a strong need to educate industry stakeholders, policymakers, and regulatory agencies about the safety and efficacy of their products. Harrisvaccines employed LS2group’s assistance for public affairs, strategic planning, and government affairs support beginning in 2012.
Each time antiquated regulations threatened Harrisvaccines’ core business model, LS2group worked closely with policymakers and key influential stakeholders in the agriculture industry to educate them on the important work of Harrisvaccines and activate call and letter support campaigns. LS2group successfully leveraged the team’s wide range of relationships with key stakeholders in the business, agriculture, and political communities to establish positive connections for Harrisvaccines management and familiarize stakeholders with Harrisvaccines’ unique technology. Through the tactics outlined above and many more, LS2group and Harrisvaccines have been successful in stopping legislation that would jeopardize Harrisvaccines’ core business model. Harrisvaccines has received a number of regulatory approvals from the USDA in recent years that have allowed the company to grow and flourish.